Dr Batra’s®, a pioneer of modern homeopathy in India, has launched Dr Batra’s® XODerma—a breakthrough in skin rejuvenation and the first treatment of its kind in the country to combine homeopathy with advanced skin exosome technology. This non-injectable, non-invasive and painless therapy helps individuals achieve ageless, spotless skin safely and comfortably, with visible improvements in just three sessions.
Powered by Exosome Science for Deeper Skin Renewal
At the core of XODerma lies exosome science. Exosomes are highly targeted, nano-sized biological messengers that penetrate deep into the skin layers. Consequently, they activate natural repair and regeneration processes at the cellular level. Rather than offering temporary, surface-level cosmetic benefits, XODerma delivers longer-lasting improvements by enhancing skin texture, tone, firmness and clarity over time.
Leadership Perspective on Innovation and Patient Safety
Commenting on the launch, Dr Akshay Batra, Trichologist, Fellowship in Homeopathic Cosmetology & Aesthetics and Managing Director, Dr Batra’s® Healthcare, said, “At Dr Batra’s®, patient-centric innovation remains at the heart of everything we do. Following the successful introduction of exosome-based hair treatments in India, we are pleased to bring XODerma, a globally recognised skin rejuvenation therapy, to our patients. With increasing skin concerns driven by pollution, stress, ageing and demanding lifestyles, people are seeking treatments that are quick, effective and, above all, safe. XODerma delivers visible improvements in skin texture, tone and firmness within three sessions. By integrating advanced exosome science with our commitment to natural, side-effect–free care, we aim to provide healthier, youthful and glowing skin in the most comfortable way possible.”
An Integrative Approach for Holistic Skin Health
What truly sets XODerma apart is its integrative treatment model. On one hand, exosome technology targets skin repair and regeneration externally. On the other hand, personalised homeopathic medicines work internally to address the root causes of pigmentation and skin ageing, such as hormonal imbalances, nutritional deficiencies, stress and lifestyle-related factors. As a result, this dual-action approach promotes internal balance while supporting sustained external skin renewal.
Enriched with Clinically Backed Skin Actives
In addition to exosomes, XODerma features a powerful combination of scientifically validated skin actives. Peptides help smooth fine lines and enhance skin firmness. Meanwhile, hyaluronic acid deeply hydrates and plumps the skin. PDRN stimulates collagen production and supports DNA repair, while adenosine accelerates skin renewal and improves overall skin quality. Together, these ingredients enhance radiance, reduce pigmentation, improve firmness and refine skin texture.
AI-Guided, Personalised Treatment Experience
As per the press release, each XODerma session begins with an advanced AI-based skin analysis. This technology evaluates pigmentation, fine lines, pore size, texture and hydration levels in detail. Based on these insights, doctors design a personalised treatment plan tailored to individual skin needs.
Subsequently, the procedure starts with deep cleansing to prepare the skin. Doctors then create micro-channels using a derma pen, allowing precise, non-injectable delivery of exosomes and active ingredients into the deeper skin layers. Through targeted exosome release, the treatment ensures optimal absorption and effectiveness, while maintaining high standards of comfort and safety.
Transparent Outcomes with Scientific Validation
Finally, at the completion of the treatment cycle, patients receive a comprehensive outcome report generated through AI-based skin reassessment. This report clearly compares pre- and post-treatment skin health, highlighting reductions in pigmentation, improved skin tone, enhanced firmness and visible refinement in skin texture. In doing so, XODerma offers transparency, measurable outcomes and scientific validation of results.




















